CAR T-Cell Therapy Shows Race-Agnostic Response in MM Patients
American Society of Hematology
Multiple myeloma patients treated with CAR T-cell therapy showed similar survival outcomes regardless of race or ethnicity
Multiple myeloma patients treated with CAR T-cell therapy showed similar survival outcomes regardless of race or ethnicity
Fighting relapsed/refractory lymphoma during pregnancy requires critical decision-making from patients and providers